Tradeline, Inc. filters and categorizes new-construction and industry news from regional and professional journals across the country. Here you will find new projects, products, and regulatory updates.
Industry News
Centre for Addiction and Mental Health Begins Construction on Research Facility
The Centre for Addiction and Mental Health (CAMH) began construction in January of 2024 on the Research & Discovery Centre in Toronto. Designed by TreanorHL and KPMB Architects, the 389,341-sf facility will catalyze the translation of medical breakthroughs into new solutions for patient care. This centralized home for CAMH’s research enterprise will feature open lab and office environments, space for clinical trials, and communal settings illuminated by natural light.
Washington University in St. Louis Opens Neuroscience Research Building
Washington University in St. Louis opened the $616 million Jeffrey T. Fort Neuroscience Research Building in January of 2024. Designed by Perkins&Will and CannonDesign, the 608,825-sf facility provides interactive lab neighborhoods where up to 120 teams can engage in collaborative discovery. An 11-story, 584,050-sf research tower is capable of accommodating up to 1,000 investigators from the departments of neurology, neuroscience, neurosurgery, psychiatry, and anesthesiology.
University of Nebraska at Kearney Constructs Rural Health Education Building
The University of Nebraska is constructing the $95 million Kristensen Rural Health Education Building on its Kearney campus. Created in collaboration with the University of Nebraska Medical Center, the 114,000-gsf facility will accommodate programs in medicine, nursing, and allied health, as well as offering professional development, training, and continuing education opportunities.
XBiotech Expands Austin Headquarters
Global pharmaceutical firm XBiotech will break ground in early 2024 on an expansion of its Austin campus. Designed by MOD Architecture, the 46,000-sf R&D center will catalyze the discovery and development of innovative biomedical therapies, as well as accelerating the commercialization of the company’s Natrunix rheumatology treatment. Wet laboratories for infectious disease research will foster the creation of new vaccines and medications to address emerging health challenges.
AstraZeneca Partners with Boston Properties on Cambridge R&D Center
AstraZeneca is partnering with Boston Properties to create a 570,000-sf R&D center in Cambridge’s Kendall Square. Housing approximately 1,850 employees, the 16-story building will offer world-class research environments for the creation of advanced biomedical therapies and vaccines. This nexus of innovation and discovery will feature flexible open laboratories arranged in neighborhoods with shared instrumentation suites and collaboration spaces.